The co-engagement of the inhibitory immune checkpoint CD47 with GPC3 to generate a GPC3-CD47 BsAb which could enhance the Fc-mediated effector functions against HCC through both neutrophil and macrophage-dependent mechanisms [218]. Here, CD47 is linked to hepatocellular carcinoma.